weight-loss drugs
FDA Proposal Set to Cut Biocon's Biosimilar Development Costs by Half: Impact on Global Healthcare Access
Nov 14, 2025 03:04 am CST
India's Biocon anticipates a 50% reduction in biosimilar development costs following the FDA's proposal to simplify clinical testing requirements. The company, which reported 25% growth in biosimilar revenue and holds significant U.S. market share for oncology medications, plans to launch 20 biosimilars by 2030 while expanding into the weight-loss drug market.
Man Faints Behind President Trump During White House Drug Pricing Announcement Event
Nov 07, 2025 10:16 am CST
During a White House ceremony announcing reduced prices for popular weight-loss medications, an unexpected medical incident occurred when a pharmaceutical company representative fainted behind President Trump. The event, which featured executives from Eli Lilly and Novo Nordisk, was briefly paused before Trump revealed significant price cuts for GLP-1 medications like Wegovy and Zepbound.